PBH Prestige Brand Holdings Inc

$66.74

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/22/2025

About Prestige Brand Holdings Inc

Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company is headquartered in Tarrytown, New York.

Website: https://www.prestigebrands.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
March
CIK
1295947
Address
660 WHITE PLAINS RD., TARRYTOWN, NY, US
Valuation
Market Cap
$3.98B
P/E Ratio
18.85
PEG Ratio
2.66
Price to Book
2.22
Performance
EPS
$4.26
Dividend Yield
Profit Margin
19.10%
ROE
12.60%
Technicals
50D MA
$84.51
200D MA
$77.12
52W High
$90.04
52W Low
$62.35
Fundamentals
Shares Outstanding
50M
Target Price
$86.67
Beta
0.47

PBH EPS Estimates vs Actual

Estimated
Actual

PBH News & Sentiment

Aug 07, 2025 • Zacks Commentary NEUTRAL
Prestige Consumer Healthcare ( PBH ) Misses Q1 Earnings and Revenue Estimates
Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of -5.94% and -4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 07, 2025 • Motley Fool SOMEWHAT-BULLISH
Prestige ( PBH ) Q1 Revenue Falls 6.6%
Prestige Consumer Healthcare ( NYSE:PBH ) , the over-the-counter ( OTC ) healthcare product company behind brands such as Clear Eyes, Monistat, and Chloraseptic, released its first-quarter results for fiscal 2026 on August 7, 2025.
Aug 06, 2025 • Zacks Commentary NEUTRAL
Stay Ahead of the Game With Prestige Consumer Healthcare ( PBH ) Q1 Earnings: Wall Street's Insights on Key Metrics
Beyond analysts' top-and-bottom-line estimates for Prestige Consumer Healthcare (PBH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Aug 05, 2025 • Zacks Commentary NEUTRAL
AdaptHealth Corp. ( AHCO ) Lags Q2 Earnings and Revenue Estimates
AdaptHealth (AHCO) delivered earnings and revenue surprises of -93.33% and -0.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Jul 15, 2025 • Benzinga SOMEWHAT-BULLISH
Dolores Catania Teams Up with Advanced Herbals®, from the Makers of Dramamine®, to Launch The Dish on GLP-1s Content Series and Tackle One of the Most Common Complaints from GLP-1 Users: Nausea
Advanced Herbals® and the reality TV star are sharing new, original content aimed to help the majority ( 64% ) of GLP-1 users who wish they had more education about the medications' side effects TARRYTOWN, N.Y., July 15, 2025 /PRNewswire/ -- Side effects can crash the GLP-1 party - and most ...
Jul 15, 2025 • GlobeNewswire NEUTRAL
Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results
TARRYTOWN, N.Y., July 15, 2025 ( GLOBE NEWSWIRE ) -- Prestige Consumer Healthcare Inc. ( NYSE:PBH ) today announced that it will issue its fiscal 2026 first quarter earnings release on Thursday, August 7, 2025 before the opening of the market.
Sentiment Snapshot

Average Sentiment Score:

0.280
50 articles with scored sentiment

Overall Sentiment:

Bullish

PBH Reported Earnings

Feb 06, 2025
Dec 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $1.22
  • Estimate: $1.20
  • Whisper:
  • Surprise %: 1.7%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $1.09
  • Estimate: $1.08
  • Whisper:
  • Surprise %: 0.9%
Aug 08, 2024
Jun 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.90
  • Estimate: $0.86
  • Whisper:
  • Surprise %: 4.7%
May 14, 2024
Mar 31, 2024 (Post market)
-0.16 Surprise
  • Reported EPS: $0.98
  • Estimate: $1.14
  • Whisper:
  • Surprise %: -14.0%
Feb 08, 2024
Dec 31, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $1.06
  • Estimate: $1.04
  • Whisper:
  • Surprise %: 1.9%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $1.07
  • Estimate: $1.07
  • Whisper:
  • Surprise %: 0.0%
Aug 03, 2023
Jun 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $1.06
  • Estimate: $1.01
  • Whisper:
  • Surprise %: 5.0%
May 04, 2023
Mar 31, 2023 (Pre market)
-5.87 Surprise
  • Reported EPS: $-4.83
  • Estimate: $1.04
  • Whisper:
  • Surprise %: -564.4%
Feb 02, 2023
Dec 31, 2022 (Pre market)
0.03 Surprise
  • Reported EPS: $1.04
  • Estimate: $1.01
  • Whisper:
  • Surprise %: 3.0%

Financials